These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
644 related items for PubMed ID: 23768157
1. Aberrant B cell selection and activation in systemic lupus erythematosus. Kil LP, Hendriks RW. Int Rev Immunol; 2013 Aug; 32(4):445-70. PubMed ID: 23768157 [Abstract] [Full Text] [Related]
4. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, Suzuki J, Nozawa K, Amano H, Tokano Y, Kobata T, Takasaki Y. Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077 [Abstract] [Full Text] [Related]
6. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus. Lajaunias F, Ida A, Kikuchi S, Fossati-Jimack L, Martinez-Soria E, Moll T, Law CL, Izui S. Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829 [Abstract] [Full Text] [Related]
9. Emerging and critical issues in the pathogenesis of lupus. Gatto M, Zen M, Ghirardello A, Bettio S, Bassi N, Iaccarino L, Punzi L, Doria A. Autoimmun Rev; 2013 Feb; 12(4):523-36. PubMed ID: 23000207 [Abstract] [Full Text] [Related]
11. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. Devi BS, Van Noordin S, Krausz T, Davies KA. J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931 [Abstract] [Full Text] [Related]
12. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Grimaldi CM. Curr Opin Rheumatol; 2006 Sep; 18(5):456-61. PubMed ID: 16896282 [Abstract] [Full Text] [Related]
13. Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects. Soni C, Reizis B. Front Immunol; 2019 Sep; 10():1601. PubMed ID: 31354738 [Abstract] [Full Text] [Related]
14. Pharmacotherapy of systemic lupus erythematosus. Francis L, Perl A. Expert Opin Pharmacother; 2009 Jun; 10(9):1481-94. PubMed ID: 19505215 [Abstract] [Full Text] [Related]
15. B cell transcription factors: Potential new therapeutic targets for SLE. De S, Barnes BJ. Clin Immunol; 2014 Jun; 152(1-2):140-51. PubMed ID: 24674882 [Abstract] [Full Text] [Related]
16. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus. Jones SA, Toh AE, Odobasic D, Oudin MA, Cheng Q, Lee JP, White SJ, Russ BE, Infantino S, Light A, Tarlinton DM, Harris J, Morand EF. Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340 [Abstract] [Full Text] [Related]
18. The role of innate immune responses in autoimmune disease development. Waldner H. Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250 [Abstract] [Full Text] [Related]
19. Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus. De Groof A, Hémon P, Mignen O, Pers JO, Wakeland EK, Renaudineau Y, Lauwerys BR. Clin Rev Allergy Immunol; 2017 Oct; 53(2):181-197. PubMed ID: 28500565 [Abstract] [Full Text] [Related]
20. B cells biology in systemic lupus erythematosus-from bench to bedside. Zhao L, Ye Y, Zhang X. Sci China Life Sci; 2015 Nov; 58(11):1111-25. PubMed ID: 26563177 [Abstract] [Full Text] [Related] Page: [Next] [New Search]